Beginning as early as antibody cloning or as late as commercial manufacturing, JHL will work with your team.
For Phase III clinical trials, materials will be manufactured, packaged, and labeled at our commercial manufacturing facility under cGMP.
The production CHO cell line is then used for the subsequent steps.
including those methods to be used as Quality Control assays, are developed.
that binds the target of interest, that contains the ideal biological characteristics agreed upon by the Client and JHL.
Cras vel dolor ultrices ligula egestas luctus et vitae odio. Curabitur dolor dolor.